Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

General information: what is glycemia in diabetes Type 2 diabetes is characterized by a constant deterioration of beta cell function, so treatment should be dynamic, involving a gradual increase in drug intervention as the disease progresses.Ideally, the blood glucose level should be maintained within the limits close to normal: before meals, blood glucose is 5-7 …

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes Read More »